1Vazquez MJ,Alvarez HE.Primary prevention in rheumatology:the importance of hyperuricemia[J].Best Pract Res Clin Rheumatol,2004,18(2):111-124. 被引量：1
2Johnson RJ,Kang DH,Feig D,et al.Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease[J] ? Hypertension,2003,41 (6):1183-1190. 被引量：1
3Okada H,Danoff TM,Kalluri R,et al.Early role of Fspl in epithelial-mesenchymal transformation[J].Am J Physiol,1997,273 (4pt2):F563-F574. 被引量：1
4Ikenouchi J,Matsuda M,Furuse M,et al.Regulation of tight junctions during the epithelium-mesenchyme transition:direct repression of the gene expression of claudins/occluding by Snail[J].J Cell Sci,2003,116 (pt10):1959-1967. 被引量：1
5Watanabe S,Kanellis J.Reducing uric acid as a means to prevent cardiovascular and renal disease,expert opinion on therapeutic patents[J].2002,12 (2):193-199. 被引量：1
6Emmerson BT,Cross M,Osborne JM,et al.Ultrastructural studies of the reaction of urate crystals with a cultured renal tubular cell line[J].Nephron,1991,59(3):403-408. 被引量：1
7Toblli J E,DeRose G,Lago N,et al.Potassium citrate administration ameliorates tubulointerstial lesions in rats with uric acid nephropathy[J].Clin Nephrol,2001,55(1):59 -68. 被引量：1
8Bluestone R,Brady S,Waisman J,et al.Expcrimental hyperuricemic nephropathy:A model for human urate deposition disease[J].Arthritis Rheum,1975,18(Suppl):823-834. 被引量：1
9Kang DH,Nakagawa T,Feng L,et al.1 A role for uric acid in the progression of renal disease[J].J Am Soc Nephrol,2002,13(12):2888-2897. 被引量：1
10Sanchez-Lozada LG,Nakagawa T,Kang DH,et al.Hormonal and cytokine effects of uric acid[J].Cur Opin Nephrol Hypertens,2006,15 (1):30 -33. 被引量：1
二级参考文献5
1Johnson RJ, Kang DH, Feig D,et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?Hypertension,2003,41:1183-1190. 被引量：1
